Assisted reproductive technology includes fertility testing devices in which both eggs and embryos are handled. In this procedure, pasteurized eggs are surgically taken from a woman’s ovaries and fuses with the sperm in the laboratory and returning them to the woman’s body or donating them to another woman. The infertility problem has aggravated in many parts of the world underscoring the need for technological expertise to address the issue. Development in medical technology has brought forth Assisted Reproductive Technology (ART) which is acting as savior for infertility treatment. The infertility rate is rising worldwide owing to the increasing obesity cases, increasing stress levels, changing life styles, poor nutrition, smoking and excessive alcohol & drug consumption. Increasing prevalence rate of conditions such as poly-cystic ovarian syndrome (PCOS), tubal factors and endometriosis are also the factors for infertility.
With a projected growth rate of 9.8% from 2023 to 2032, the global assisted reproductive technology market, which was valued at USD 26.30 billion in 2022, is expected to reach approximately USD 66.73 billion by 2032.
According to the Centers for Disease Control and Prevention (CDC) estimation, about 10% of women in the United States ages 15-44 suffer from impaired fecundity, whereas 6.8% of married women in the same age groups are infertile. Thus, the infertility cases worldwide propel the demand for assisted reproductive technologies market. One of the other major factors is rise in the number of same- sex couples and single women globally due to which fertility treatment procedures such as ART are adopted widely. The rising per capita disposable income level of individuals across the world has created potential for men and women who are not able to conceive to be able to undergo fertility treatments are increasing. The government provides funds for research, which can help patients with better success rates and economical cost along with various favorable reimbursement policies. Increase in awareness for in-vitro fertilization and surrogacy are driving the market of assisted reproductive technology. Wide number of government and non-profit agencies in the developing or developed countries are providing awareness campaigns to educate the general public regarding the effect and cost-effective fertility treatment. Technological advancements is also one of the contributing factors for the market growth.
In-vitro fertilization (IVF) technology dominated the assisted reproductive technology market
In vitro fertilization (IVF) process consists fertilization of egg cells by sperm outside the body, in a laboratory dish, and then implanting it in a woman's uterus. It is used to treat fertility or genetic problems to assists with the conception of child. The embryo(s) is then transferred to the uterus for further gestation. In-vitro fertilization has high procedural success rate along with development in IVF technology are the positive growth factor. Large population pool is seeking IVF treatment for problems associated with infertility. The market is driven by increasing incidence of infertility owing to lifestyle changes, government initiatives to provide better reimbursement policies and cost effectivity are the factors flourishing this market segment. Standardization of procedures through automation, regulatory reforms, and government funding for egg/sperm storage are some of the factors influencing positive growth.
Europe to dominate the global assisted reproductive technologies market
Europe dominated the global assisted reproductive technology market and is expected to retain its dominance in the coming year owing to rising awareness among people for infertility treatment, technological advancements, government initiatives to promote appropriate assisted reproductive technology facilities, and increasing number of infertility cases in the region. The Centers for Disease Control and Prevention (CDC) have developed the National Public Health Action Plan with an aim to avoid, spot, improved efficacy safe treatment and manage the infertility cases around the world. Maximum of the Europe Member States have considered infertility a medical condition and their national policies fund ranges from the entire treatment to some portion of infertility treatment. All the aforementioned factors are expected to propel the growth of this market in this region.
Key Market Players
• CooperSurgical Inc.
• Ferring B.V.
• Hamilton Thorne Inc.
• FUJIFILM Irvine Scientific, Inc.
• Nidacon International AB
• Carolinas Fertility Institute
• Apollo Hospitals Enterprise Ltd.
• California Cryobank
• European Sperm Bank
Following is a detailed snapshot of most prominent segments in global electronic lab notebook market:
assisted reproductive technology (ART) market Scope
Metrics | Details |
Base Year | 2023 |
Historic Data | 2018-2022 |
Forecast Period | 2024-2032 |
Study Period | 2018-2032 |
Forecast Unit | Value (USD) |
Revenue forecast in 2032 | USD 66.73 billion |
Growth Rate | CAGR of 9.8 % during 2022-2032 |
Segment Covered | By Type Technology, By Procedure Outlook , Region. |
Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
Key Players Profiled | Cosmos Biomedical Ltd., Microm UK Ltd., CooperSurgical Fertility Solutions, FUJIFILM Irvine Scientific, Cryolab Ltd., Parallabs Ltd., European Sperm Bank, Ovascience Inc., Bloom IVF, and Ferring Pharmaceuticals. |
Segmentation by technology: Global Assisted Reproductive Technologies Market
• In-Vitro Fertilization (IVF)
• Artificial Insemination (AI-IUI)
• Frozen Embryo Replacement (FER)
• Others
Segmentation by procedure type: Global Assisted Reproductive Technologies Market
• Fresh Non Donor
• Fresh Donor
• Frozen Donor
• Frozen Non donor
• Embryo/Egg Banking
Segmentation by End user: Global Assisted Reproductive Technologies
• Hospital
• Fertility Clinics
• IVF Center
Regional Segmentation: Global Assisted Reproductive Technologies
• North America
• Europe
• Asia
• Central & South America
• Middle East & Africa
Key Market Movements
• Favorable policies of reimbursement and the introduction of new technology are some of the factors contributing to the market growth
• Changing life style and rising number infertility issues fuels growth of this market
• Emergence of new technologies and innovations in assisted reproductive technology are the growth opportunities
• Growing R&D activities and development in IVF technology are the positive growth factor
Key Questions Answered
• Market valuation in terms of value and volume of the in global assisted reproductive technology market
• through the forecast span, 2019-25
• Comprehensive market evaluation across major regions based on market segmentation
• A thorough rundown on market dynamics such as drivers, threats, challenges, and opportunities
• A clear analytical review of competition spectrum, highlighting industry forerunners, company as well as product portfolios
• Major highlights on winning marketing strategies adopted by leading players